Search Tag: Renal replacement therapy

ICU Management

Renal Replacement Therapy in Critically Ill Patients with AKI

2021 01 Jun

Many critical care patients with severe acute kidney injury (AKI), especially those who develop refractory complications, receive renal replacement therapy (RRT). However, when RRT should be initiated for these patients remains unclear. There is a consensus that in patients with urgent or refractory complications, RRT should be started. However, the... Read more

ICU Management

Delayed Initiation Strategy for Renal Replacement Therapy

2021 13 Apr

Delaying renal replacement therapy (RRT) in critically ill patients with severe kidney injury and no severe complication is safe and can allow optimisation of the use of medical devices. However, uncertainty still remains regarding the duration for which RRT can be delayed without risk to the patient. In this study, the researchers evaluate a more-delayed... Read more

ICU Management

Oliguria And The Role Of Urine Monitoring In Renal Replacement Therapy (RRT) Management

2020 28 Jul

ABSTRACT Renal Replacement Therapy (RRT) is a complex treatment modality for a high-risk, critical care patient population with advanced AKI. While there are still no clear guidelines regarding the timing of initiation and termination of RRT, there is a growing body of evidence supporting the importance of urine monitoring and the clinical significance... Read more

ICU Management

The Importance Of Continuous Monitoring Of Urine Flow In Critical Care Patients

2020 30 Jun

ABSTRACT This review discusses the importance of continuous, real-time monitoring of urine flow in critical care patients and its potential role in Acute Kidney Injury (AKI) and fluid management in a variety of clinical conditions.  Real-time, reliable monitoring of urine flow enables clinicians to detect early signs of kidney injury, and facilitates... Read more

ICU Management

Patients with AKI and sepsis: when to initiate renal-replacement therapy

2018 17 Oct

Among patients with septic shock who had severe acute kidney injury (AKI), there was no significant difference in overall mortality at 90 days between patients who were assigned to an early strategy for the initiation of renal-replacement therapy and those who were assigned to a delayed strategy, according to a randomised controlled trial published... Read more

ICU Management

Managing renal replacement therapy in AKI patients

2018 23 Jan

It is estimated that 22–57% of critically ill patients develop acute kidney injury (AKI) during their hospitalisation. The increasing incidence of AKI has the immediate effect of a growing need for renal replacement therapy (RRT). However, evidence on how to manage RRT in critically ill patients with AKI remains limited because of ambiguous study results... Read more

ICU Management

Volume 16 - Issue 4, 2016

2016 30 Nov

Change content default value Read more

ICU Management

Renal Replacement Therapy for Acute Kidney Injury: Questions Remain

2016 30 Nov

Eric Hoste is Professor in Medicine and Head of Clinic at Ghent University Hospital, Belgium. Prof. Hoste’s primary clinical area of interest is clinical critical care nephrology, and he has published more than 190 original papers, review articles and book chapters primarily within this field. He is a Senior Clinical Investigator, Research Foundation-Flanders... Read more

ICU Management

Optimal Timing of Renal Replacement Therapy ‘Elusive’

2016 24 May

A clear answer for the optimal timing of RRT in critical illness remains elusive, say the authors of a systematic review published in Critical Care . They recommend that clinicians refrain from lowering their clinical thresholds for implementing RRT in critical care patients with acute renal injury. Studies on the timing of renal replacement therapy... Read more

ICU Management

ELAIN Trial for AKI: Significant Mortality Reduction in Early RRT Group

2016 22 May

Results of the Early vs Late Initiation of Renal Replacement Therapy in Critically Ill Patients With Acute Kidney Injury (ELAIN) Trial found a significant reduction in 90-day all-cause mortality in the early initiation group. The single-centre study, by Alexander Zarbock , MD, of University Hospital Munster, Germany, and colleagues, which is to be... Read more